Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: DWF Sets Up New Global Operating Structure

Thu, 14th Jan 2021 19:15

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

DWF Group PLC - Manchester-based law firm - Sets up new internal operating structure, effective from May 1. Streamlines into three global units: Legal Advisory; Mindcrest; and Connected Services. Moves from current 4 divisions: Commercial Services; Insurance Services; International; and Connected Services. "Together, the three divisions will support DWF's single Integrated Legal Management approach through which the group can seamlessly combine any number of these services to deliver bespoke solutions to its clients with greater efficiency, price certainty and transparency. This approach enables DWF to offer clients solutions that combine traditional law firm services with new, modern legal and business services relevant to today's companies and the challenges and opportunities they face," company adds.

----------

Schroder UK Public Private Trust PLC - investment trust - Amends existing credit facility to extend the term for 24 months to January 30, 2023. The commitment under the facility has been reduced to GBP107.0 million, in-line with the amount currently drawn under the facility and consistent with the company's intention to reduce borrowings. The annual interest rate will be the Bank of England Bank Rate plus 2.0%. The facility will convert to a revolving credit facility with a size of GBP60 million once the loan balance reaches a GBP60 million outstanding balance.

----------

Tufton Oceanic Assets Ltd - invests in portfolio of second-hand commercial sea-going vessels - Buys one containership for USD7.0 million. This acquisition takes the company's fleet to twenty-one vessels. The vessel has a floating rate time charter, subject to a floor and a ceiling, of at least three years to a major container line which is investment grade, Tufton says. "The yield during the charter exceeds the targets expressed in the company's prospectus dated September 25, 2018. The vessel's share of expected fuel cost savings produced by the scrubber increases the yield to greatly in excess of the company's targets," company adds.

----------

Sensyne Health PLC - Oxford-based clinical artificial intelligence company - launches MagnifEye smartphone application to automate the reading and Big Data analysis of lateral flow tests using deep learning AI. "MagnifEye uses a cloud-based deep learning algorithm to automate the accurate reading and analysis of lateral flow diagnostic tests, such as for Covid-19, providing standardised results in under 2 seconds," company explains.

----------

Gulf Investment Fund PLC - investment firm focused on opportunities and positive fundamental factors in the Gulf Cooperation Council - Confirms that all assets in the tender pool have been sold. As of Janaury 12, the final tender offer asset value was USD60.7 million, giving a tender price of USD1.4941. Firm proposing to hold 5.8 million tendered shares in treasury, with the remaining 34.9 million tendered shares being cancelled.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Extends exclusive licence arrangement for Alkindi with Eton Pharmaceuticals Inc to include Canada. Licence for US only so far. In addition, company granted a key Canadian patent claiming method of treatment for Alkindi. Diurnal notes earlier Thursday Alkindi product sales for the six months ended December 31 increased to GBP1.2 million, up 4% year-on-year from GBP1.1 million. Says total revenue, including licence income, up 6% year on year to GBP1.2 million.

----------

IronRidge Resources Ltd - Australia-based minerals exploration company - Starts drilling at the Ewoyaa lithium project, where it has defined a JORC compliant mineral resource estimate of 14.5 million tonnes at 1.31% Li2O in the inferred and indicated category, including 4.5 million tonnes at 1.39% Li2O in the indicated category in Ghana, West Africa. First reverse circulation drill hole intersects visible spodumene on a new pegmatite target within 500 metres of the current resource. About 10,000 metres of RC drilling designed to test seven new high-priority pegmatite targets, including outcropping spodumene pegmatite within the immediate Ewoyaa lithium project area to add potential resource tonnes.

----------

Duke Royalty Ltd - London-based provider of financing solutions to private companies whose owners want to retain equity control - Completes follow-on investment of GBP2.2 million into its existing royalty partner Step Investments Ltd. Step is the holding company for a range of interests in the private education, advertising and hospitality sectors, including Pearl & Dean Cinemas Ltd. "As part of the follow-on investment, Duke's 30% equity stake in Step, partially in lieu of foregone cash royalty payments over the six month forbearance period from April 2020 to September 2020, has been confirmed, which demonstrates Duke's ability to preserve shareholder value while assisting our royalty partners," Duke adds.

----------

Thor Mining PLC - the exploration and development company with projects in Australia - Completes acquisition of additional licence areas, one of which is under application, pending approval, adjacent to Ragged Range in the Pilbara region of Western Australia. Thor will issue 12.5 million million new shares and 8.3 million options to acquire shares at AUD0.3 per share for the initial consideration. Executive Chair Mike Billing says: "We are delighted to complete this acquisition and add to our holdings adjacent to Ragged Range where we have made very encouraging progress this year. Our sampling programs and airborne magnetic survey results to date have produced exciting and encouraging results, with a further sampling program, along with assessment of drill program access requirements to commence shortly."

----------

Manx Financial Group PLC - Isle of Man-based financial services firm - Says subsidiary Conister Finance & Leasing Ltd has received approval for an increase in its lending allocation for the Coronavirus Business Interruption Loan Scheme to GBP15 million. The CBILS have an 80% indemnification for any loss and are guaranteed by the UK government. Manx Finance Director Douglas Grant says: "I am extremely pleased that CFL has been selected to provide additional government-backed funding to assist SMEs as it is clear that lenders such as ourselves continue to be recognised as a vital component in keeping the SME sector alive."

----------

LPA Group PLC - Essex-based LED lighting and electro-mechanical system manufacturer - Wins two contract awards for the UK rail market. The contracts, awarded independently to LPA Connection Systems and LPA Lighting Systems, have a combined value of GBP1.9 million and are for the supply of interior lighting and intercar power connection systems, totalling 135 cars for the Hitachi AT300 new build trains to be operated by the West Coast Partnership, on the UK's West Coast Mainline. Deliveries are due to commence by the second quarter, with a nine-month delivery span anticipated. The awards are in line with internal expectations.

----------

Petroneft Resources PLC - Russia-focused oil and gas exploration and production company - Seeks one-year extension to USD1.3 million convertible loan facility signed in June 2019. "Whilst those discussions are ongoing we are confident that we will be able to announce a successful outcome shortly," company adds.

----------

Harvest Minerals Ltd - fertiliser producer and operator of Arapua project in Brazil - Sees positive agronomic test results for carrot crops using KP Fertil, Harvest's direct application natural remineraliser produced at the company's 100% owned Arapua fertiliser project in Brazil. Chair Brian McMaster says: "The performance from the agronomic tests using our KP Fertil in carrot crops was outstanding in many aspects including soil nutrition, productivity and economic gains to the farmer. These results add to our portfolio of superior agronomical results, which have also been reported on sugarcane and coffee, among other cultures, reinforcing the versatility of our product and its wide application optionality. As with our other agronomical tests, these positive results will be instrumental for our commercial team in increasing our client portfolio."

----------

Iconic Labs PLC - media company - Served with a claim form from European High Growth Opportunities Securitization Fund. EHGOF has filed the claim in the High Court in London, but has yet to file particulars of claim setting out the exact nature of its claim, and therefore the company is unable to respond or comment in any detail on the claim until such time as EHGOF files the necessary documentation to evidence its alleged claim. "Notwithstanding the above, the company assumes that the claim may be being made in respect of amounts that are allegedly due to EHGOF under specific loan notes, although the claim form makes no reference to these loan notes, instead referring to agreements with EHGOF that were, against the wishes of EHGOF, unilaterally and validly terminated by the company last year," Iconic says. It adds: "The company reserves its position at this time on the merits of the alleged claim pending receipt of fully particularised particulars of claim and a full investigation of the claim."

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
10 Jan 2019 11:33

Diurnal Shares Surge As Secures Second Patent For Chronocort In US

LONDON (Alliance News) - Diurnal Group PLC on Thursday said the US Patent & Trademark Office has granted the company a second US patent for Chronocort.Diurnal shares almost tripled on a

Read more
10 Jan 2019 11:26

Diurnal awarded US patent for Chronocort product

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Thursday that the US Patent and Trademark Office (USPTO) has granted a second US patent for its 'Chronocort' modified release hydrocortisone product.

Read more
17 Oct 2018 12:10

Diurnal halts US development of Chronocort after European trials come up short

(Sharecast News) - Speciality pharmaceutical company Diurnal has put all development activities for its modified release hydrocortisone product on hold after it failed to meet its primary endpoint in a recent phase-three European trial.

Read more
17 Oct 2018 10:41

Diurnal Puts All Chronocort US Development Activities On Hold

LONDON (Alliance News) - Diurnal Group PLC said Wednesday it decided to put all US development activities for its Chronocort product on hold, after it failed to meet its primary objective in its a

Read more
8 Oct 2018 17:07

LONDON MARKET CLOSE: Stocks End Lower On Chinese And Italian Woes

LONDON (Alliance News) - Stocks closed lower Monday on the actions of the Chinese and Italian governments, as the pound continued its fall on news from 10 Downing Street there remains "big in of

Read more
8 Oct 2018 15:15

Diurnal Group Child Adrenal Insufficiency Drug Approved In Scotland

LONDON (Alliance News) - Diurnal Group PLC said Monday the Scottish Medicines Consortium approved the routine use of Alkindi, a first-line treatment of young children with adrenal insufficiency to

Read more
8 Oct 2018 12:00

LONDON MARKET MIDDAY: China Prompts Sell-Off In Europe; Insurers Fall

LONDON (Alliance News) - Share prices in London had slipped firmly into the red by midday on Monday following a slump in Chinese equities overnight."Europe is following the Asian lead, with a 3%

Read more
8 Oct 2018 10:33

WINNERS & LOSERS SUMMARY: French Connection In Vogue On Possible Sale

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 1.0%. The asset manager confirmed it is in to

Read more
8 Oct 2018 09:29

Diurnal's endocrine drug does not meet trial objective

(Sharecast News) - Clinical trials of Diurnal Group's Chronocort drug failed to meet the primary objective of proving superior to conventional therapy in endocrine control over a 24-hour period.

Read more
8 Oct 2018 08:54

Shares In IP Group, Diurnal Suffer After Chronocort Trial Disappoints

LONDON (Alliance News) - Diurnal Group PLC said Monday its phase-three European trial of Chronocort did not meet its primary objective, causing shares in the pharmaceutical company to property IP

Read more
8 Oct 2018 07:48

LONDON MARKET PRE-OPEN: Lower Call; Schroders Confirms Lloyds Talks

LONDON (Alliance News) - Stocks in London on Monday are set to continue last week's slide, fuelled by concerns that strong US economic data will lead to a quickened pace of interest rate hikes.In

Read more
5 Oct 2018 09:20

Diurnal kicks off adrenal condition trial with first patients

(Sharecast News) - Specialist pharmaceutical company Diurnal said it had enrolled the first two patients in its US-based Chronocort phase III trial for adults with congenital adrenal hyperplasia (CAH).

Read more
5 Oct 2018 08:16

Diurnal Enrols First Patients In Phase Three US Chronocort Trial

LONDON (Alliance News) - Pharmaceutical company Diurnal Group PLC on Friday said the first two patients have been enrolled into its phase three US trial of Chronocort.Chronocort is a form a

Read more
20 Sep 2018 09:56

Diurnal Generates First Revenue But Loss Deepens As Costs Rise

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Thursday its annual loss deepened amid higher costs despite generating its first revenue from drug sales.For the year the

Read more
15 Aug 2018 12:39

German Body Says Diurnal Alkindi's Benefit Over Generic Not Proven

LONDON (Alliance News) - Diurnal Group PLC said Wednesday a German body published a study which says that the benefit of the company's product Alkindi over generic hydrocortisone has not been

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.